Getting a semaglutide prescription starts with a medical evaluation, either through your primary care doctor, an obesity medicine specialist, or a telehealth provider. The process typically involves confirming you meet specific weight criteria, running baseline blood work, and navigating insurance coverage or out-of-pocket costs. Here’s what each step actually looks like.
Who Qualifies for a Prescription
The FDA approved semaglutide for weight management (sold as Wegovy) for adults with obesity, defined as a BMI of 30 or higher. Adults with a BMI between 27 and 29.9 can also qualify if they have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea. Pediatric patients aged 12 and older with obesity are eligible as well.
Semaglutide is also prescribed under the brand name Ozempic specifically for type 2 diabetes management, with a lower BMI threshold of 27. Some providers prescribe Ozempic off-label for weight loss, though insurance is less likely to cover it for that purpose.
There are a few conditions that rule out semaglutide entirely. If you or a close family member has a history of medullary thyroid cancer or a rare condition called Multiple Endocrine Neoplasia syndrome type 2, your doctor will not prescribe it. You should also tell your provider about any history of pancreatitis, gallbladder disease, or kidney problems before starting treatment.
Which Providers Can Prescribe It
Any licensed healthcare provider can write a semaglutide prescription. That includes primary care physicians, nurse practitioners, physician assistants, endocrinologists, cardiologists, and gastroenterologists. What matters more than the specialty is whether the provider has experience managing obesity as a chronic condition and can follow you over time. Semaglutide is not a short-term medication for most people, so you want a prescriber who will monitor your progress, adjust doses, and help manage side effects over months or years.
Some academic medical centers have dedicated weight management programs that bring together obesity medicine specialists, dietitians, psychologists, and exercise physiologists. These multidisciplinary teams can be especially helpful if you have multiple health conditions or have struggled with weight loss through other approaches. Your primary care doctor is a perfectly fine starting point, though, and can refer you to a specialist if needed.
The Telehealth Option
Several telehealth platforms now offer semaglutide prescriptions through virtual consultations. This can be a convenient route, particularly if your local providers have long wait times or limited experience with GLP-1 medications. A legitimate telehealth visit should include a thorough medical history review, blood work (either ordered through the platform or shared from your own doctor), and a real-time consultation with a licensed prescriber in your state.
Be cautious about platforms that seem to skip meaningful evaluation or offer “compounded semaglutide” as an alternative to FDA-approved versions. The FDA has warned 30 telehealth companies for illegally marketing compounded GLP-1 products, sometimes branding them under the company’s own name to make them look like approved medications. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality. They are not the same as generics. As of 2025, semaglutide is no longer on the FDA’s drug shortage list, which means the legal justification for compounding it has narrowed significantly. If a platform is pushing a compounded version, that’s a red flag.
What to Expect at Your First Visit
Your provider will take a full medical history, record your height and weight, calculate your BMI, and ask about previous weight loss attempts. They’ll want to know about any family history of thyroid cancer and whether you’ve tried structured diet or exercise programs before.
Most prescribers order baseline blood work before writing the prescription. At minimum, expect tests covering blood sugar control (HbA1c and fasting glucose), liver function, kidney function, thyroid function, and a lipid panel. These serve two purposes: they help your provider confirm that semaglutide is safe for you, and they create a baseline to measure your metabolic improvements over time. Some providers also check inflammation markers, vitamin D, iron levels, and a full blood count, especially if you’re expected to lose a significant amount of weight and may need nutritional monitoring.
Semaglutide is prescribed alongside a reduced-calorie diet and increased physical activity. Your provider may ask you to describe your current eating habits and exercise routine, and some insurance plans require documentation that you’ve been making lifestyle changes before they’ll approve coverage.
Navigating Insurance Coverage
Insurance coverage for semaglutide varies widely, and this is often the most frustrating part of the process. Many commercial insurance plans cover Wegovy for weight management, but almost all require prior authorization. That means your provider’s office submits paperwork to your insurer documenting your BMI, comorbid conditions, and sometimes proof that you’ve tried other approaches first.
Some state Medicaid programs do not cover GLP-1 medications for weight loss at all, restricting coverage to FDA-approved indications like diabetes, obstructive sleep apnea, cardiovascular risk reduction, or a specific liver condition called noncirrhotic MASH. In those programs, patients typically must demonstrate at least six months of documented lifestyle changes (healthy diet and increased physical activity) and show a plan to continue them. Additional documentation may be required depending on the condition being treated, such as proof of consistent use of a CPAP machine for sleep apnea.
If your insurer denies the prior authorization, your provider can file an appeal. Having thorough documentation of your weight history, related health conditions, and failed attempts at other interventions strengthens the case. Some patients go through two or three rounds of appeals before getting approved.
What It Costs Without Full Coverage
If you have commercial insurance that covers Wegovy, Novo Nordisk’s savings program can bring your copay down to $25 per month for a 28-day supply of injections or a 30-day supply of the oral form.
Without insurance coverage, the costs are steeper but there are still manufacturer programs available. For the injectable form, a current promotion (valid through March 31, 2026) offers the first two months at the lower starter doses for $199 per month, then $349 per month after that. The oral version has a separate offer (through April 15, 2026) at $149 per month for the lower doses, rising to $199 per month for the maintenance dose. These prices are for brand-name Wegovy purchased through the manufacturer’s program, and they’re subject to change.
Some patients look into compounded versions to save money, but with semaglutide no longer on the FDA shortage list, the availability and legality of compounded options are increasingly limited. The safest route is FDA-approved medication through a licensed provider and a reputable pharmacy.
The Dose Escalation Timeline
Semaglutide is not prescribed at full strength from day one. You’ll start at a low dose and gradually increase over several months to reduce gastrointestinal side effects like nausea, which are the most common reason people struggle early on. The typical escalation for the injectable version takes about 16 to 20 weeks before reaching the maintenance dose. Your provider will check in during this period to see how you’re tolerating the medication and whether adjustments are needed.
Most clinical trials that established semaglutide’s effectiveness ran for 68 weeks, and meaningful weight loss typically becomes apparent within the first few months. Expect your provider to order follow-up blood work periodically to track changes in blood sugar, cholesterol, and other markers that were tested at baseline.